Sunshine Biopharma, Inc. SBFM

Set alert

Price alert · SBFM

All alert types
2.74 USD -0.01 -0.37%

As of Nov 3, 9:30 AM ET

Bid
2.67 × 4
Ask
2.78 × 1
2.70 Day range 2.74
2.58 52-week range 464.00
YTD
-98.89%
1 year
-99.20%
Open
2.70
Prev close
2.75
Mkt cap
2.08M
Vol
67.80K
Avg vol
305.32K
EPS
-189.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.70
High
2.74
Forward P/E
0.02
Beta
-1.04
Short ratio
0.39
Inst. own
1.84%
Dividend
0.00
Ex-div date
50-d avg
2.80
200-d avg
25.68
1y target
300.00

1m chart

Chart tools
Interval

Built from the cached one-day intraday bars.

Signals (52)
NameTimeAgo
SMA: BearishOct 30, 4:00 PM3 days ago
SMA: BearishOct 30, 4:00 PM3 days ago
SMA: BullishOct 30, 3:59 PM3 days ago
SMA: BullishOct 30, 3:59 PM3 days ago
SMA: BearishOct 30, 3:58 PM3 days ago
SMA: BearishOct 30, 3:58 PM3 days ago
SMA: BullishOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 3:55 PM3 days ago
SMA: BearishOct 30, 3:54 PM3 days ago
SMA: BullishOct 30, 3:49 PM3 days ago
SMA: BearishOct 30, 3:48 PM3 days ago
MACD: Sell SignalOct 30, 3:47 PM3 days ago
SMA: BearishOct 30, 3:46 PM3 days ago
SMA: BullishOct 30, 3:32 PM3 days ago
SMA: BullishOct 30, 3:26 PM3 days ago
SMA: BearishOct 30, 3:25 PM3 days ago
SMA: BearishOct 30, 3:25 PM3 days ago
SMA: BullishOct 30, 3:19 PM3 days ago
SMA: BullishOct 30, 3:19 PM3 days ago
SMA: BearishOct 30, 3:18 PM3 days ago

Newest 20 of 52.

Analyst view

Consensus: none

Price target (mean) 300.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SBFM analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.000.000.0%12.50M+62.8%0
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year0.000.00 – 0.000.000.0%27.78M+15.3%0
Next year0.000.00 – 0.000.000.0%100.00M+260.0%0

Upgrades and downgrades

The latest rating changes

SBFM analyst upgrades and downgrades
DateFirmActionFromTo
Dec 5, 2024Aegis CapitalReiteratedBuyBuy
Aug 7, 2023Aegis CapitalInitiated—Buy